Skip to main content
OpenTrials
Completed

NCT Number: NCT01414647

The Health Effect of Diet Rich in Nordic Berries

Dietary polyphenols might have beneficial effects on glucose and lipid metabolism based on the studies made in animals or cell cultures. The findings regarding the possible decrease of low-grade inflammation are existing also in humans. Low-grade inflammation has been suggested to be a mechanistic link between obesity and its consequences on cardiometabolic health. The aim of the present study is to examine the effect of diet rich in berries on glucose and lipid metabolism and inflammatory markers.

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Eastern Finland, Dpet of Public Health and Clinical Nutrition

Kuopio, FIN-70211, Finland

About this study

Berries are traditionally an important part of the Nordic diet. About 50 different berries are grown in the northern region, and about half of them are edible. Phenolic compounds are one of the most diverse group of secondary metabolites present in edible plants, and berries are especially rich in them. Flavonoids, phenolic acids, lignans and complex phenolic polymers (polymeric tannins) are typical for berries. Phenolic compounds are reported to have a variety of beneficial biological properties. They are potent antioxidants, and exhibit various other physiological activities including anti-inflammatory, antimicrobial, antiallergic, anticarcinogenic and antihypertensive activities. Epidemiological studies indicate that diet rich in phenolic compound correlates with lower risk of cancer and cardiovascular disease.

The aim of the present study is to examine the effect of diet rich in berries on glucose and lipid metabolism and inflammatory markers and gene expression profile in peripheral blood mononuclear cells (PBMCs) in subjects with features of metabolic syndrome.

Randomized, controlled clinical intervention including 4 wk run-in period, 8 wk dietary intervention and 4 wk recovery period was conducted.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • overweight (BMI 26-39 kg/m2), and two of the following:
  • elevated fasting plasma glucose in the absence of diabetes (5.6-6.9 mmol/l)
  • abnormal serum lipid concentration: fasting serum triglyceride concentration >1.7 mmol/L, fasting serum HDL cholesterol <1.0 mmol/L (males) or <1.3 mmol/L (females))
  • waist circumference >102 cm (males) or >88 cm (females)
  • blood pressure >130/85 mmHg

Exclusion criteria

  • chronic diseases
  • use of lipid lowering medication

Treatment and study plan

300 g of strawberry, raspberry and cloudberry

Dietary Supplement

100 g of strawberry puree, 100 g of frozen raspberries and 100 g frozen cloudberries were concumed daily for 8 weeks. Bilberry consumption was restricted.

400 g of bilberry

Dietary Supplement

Equivalent amount to 400 g of fresh bilberries were consumed as 40 g of dried bilberries and as 200 g of frozen bilberries. Restriction of use of strawberries, raspberries and cloudberries were set.

Control diet

Other

Control diet, ie. habitual diet with restriction of berry consumption was consumed for eight weeks

Other names: Diet with restricted consumption of berries.

Primary outcomes

  1. Glucose level

    Time frame: week 8

    Fasting glucose level oral glucose tolerance status at study week 8

  2. Cholesterol level

    Time frame: week 8

    total, HDL and LDL cholesterol level at the study week 8

  3. Inflammation markers

    Time frame: week 8

    Various inflammation markers were measured at the study week 8

Secondary outcomes

  1. Markers of sterol metabolism

    Time frame: week 8

    Markers of cholesterol absorption and synthesis were measured

  2. gene expression in PBMCs

    Time frame: study week 8

    Global gene expression analyses in peripheral mononuclear cells (PBMC)

Sponsors and collaborators

Lead sponsor

Marjukka Kolehmainen

Other

Collaborators

  • VTT Technical Research Centre, Finland

Registry information

Official study title

The Effect of Diet Rich in Nordic Berries on Gut Microbiota, Glucose and Lipid Metabolism and Metabolism on Fenolic Compounds

Acronym: Berry

Important dates

Study start
2006
Primary completion
2006
Study completion
2010
First posted
Aug 11, 2011
Registry last updated
May 17, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.